Briaud Financial Planning’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.27M Hold
1,056
0.33% 13
2026
Q1
$971K Buy
1,056
+8
+0.8% +$8.11K 0.25% 14
2025
Q4
$1.13M Sell
1,048
-7
-0.7% -$6.69K 0.28% 14
2025
Q3
$805K Sell
1,055
-139
-12% -$103K 0.26% 13
2025
Q2
$930K Hold
1,194
0.37% 11
2025
Q1
$986K Hold
1,194
0.39% 10
2024
Q4
$921K Buy
1,194
+1,048
+718% +$868K 0.38% 11
2024
Q3
$129K Hold
146
0.07% 34
2024
Q2
$132K Hold
146
0.08% 33
2024
Q1
$114K Buy
+146
New +$104K 0.06% 34
2023
Q4
Sell
-146
Closed -$78K 96
2023
Q3
$78K Buy
+146
New +$75.2K 0.06% 46

Other funds holding LLY

Briaud Financial Planning's LLY Position: Q2 2026 in Review

Briaud Financial Planning held its Eli Lilly (LLY) position steady in Q2 2026 at 1,056 shares worth $1.27M. The position accounts for 0.33% of the portfolio, ranked #13.

Briaud Financial Planning first reported a position in LLY in Q3 2023 and has held it in 11 quarters since. 4,631 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Briaud Financial Planning held 1,056 shares of Eli Lilly worth $1.27M as of Q2 2026.
  • Briaud Financial Planning left its Eli Lilly share count unchanged in Q2 2026.
  • Eli Lilly made up 0.33% of Briaud Financial Planning's portfolio in Q2 2026, its #13 holding.
  • Briaud Financial Planning first reported a position in Eli Lilly in Q3 2023 and has held it in 11 quarters since.
  • 4,631 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Briaud Financial Planning's 13F filing for Q2 2026, filed 30 Jul 2026.